212 related articles for article (PubMed ID: 22112470)
1. Cancer stem cells and markers: new model of tumorigenesis with therapeutic implications.
Natarajan TG; Ganesan N; Fitzgerald KT
Cancer Biomark; 2010; 9(1-6):65-99. PubMed ID: 22112470
[TBL] [Abstract][Full Text] [Related]
2. Markers in normal and cancer stem cells.
Natarajan TG; FitzGerald KT
Cancer Biomark; 2007; 3(4-5):211-31. PubMed ID: 17917151
[TBL] [Abstract][Full Text] [Related]
3. Good cells gone bad: the cellular origins of cancer.
Wang JC
Trends Mol Med; 2010 Mar; 16(3):145-51. PubMed ID: 20149745
[TBL] [Abstract][Full Text] [Related]
4. Cancer stem cell markers in common cancers - therapeutic implications.
Klonisch T; Wiechec E; Hombach-Klonisch S; Ande SR; Wesselborg S; Schulze-Osthoff K; Los M
Trends Mol Med; 2008 Oct; 14(10):450-60. PubMed ID: 18775674
[TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer stem cells.
Yeung TM; Mortensen NJ
Dis Colon Rectum; 2009 Oct; 52(10):1788-96. PubMed ID: 19966616
[TBL] [Abstract][Full Text] [Related]
6. [Advancement of studies on ALDH1 as a universal marker of stem cells].
Han M; Wu C
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Oct; 27(5):1183-6. PubMed ID: 21089696
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer stem cells.
Vaiopoulos AG; Kostakis ID; Koutsilieris M; Papavassiliou AG
Stem Cells; 2012 Mar; 30(3):363-71. PubMed ID: 22232074
[TBL] [Abstract][Full Text] [Related]
8. Cancer stem cells: a step toward the cure.
Boman BM; Wicha MS
J Clin Oncol; 2008 Jun; 26(17):2795-9. PubMed ID: 18539956
[No Abstract] [Full Text] [Related]
9. Can lung cancer stem cells be targeted for therapies?
Wu X; Chen H; Wang X
Cancer Treat Rev; 2012 Oct; 38(6):580-8. PubMed ID: 22436486
[TBL] [Abstract][Full Text] [Related]
10. Liver cancer stem cells: implications for a new therapeutic target.
Lee TK; Castilho A; Ma S; Ng IO
Liver Int; 2009 Aug; 29(7):955-65. PubMed ID: 19490415
[TBL] [Abstract][Full Text] [Related]
11. Cancer stem cells: characteristics and their potential role for new therapeutic strategies.
Bohl SR; Pircher A; Hilbe W
Onkologie; 2011; 34(5):269-74. PubMed ID: 21577035
[TBL] [Abstract][Full Text] [Related]
12. Self-renewal gene tracking to identify tumour-initiating cells associated with metastatic potential.
Darini CY; Pisani DF; Hofman P; Pedeutour F; Sudaka I; Chomienne C; Dani C; Ladoux A
Oncogene; 2012 May; 31(19):2438-49. PubMed ID: 21927026
[TBL] [Abstract][Full Text] [Related]
13. Small molecules with big effects: the role of the microRNAome in cancer and carcinogenesis.
Koturbash I; Zemp FJ; Pogribny I; Kovalchuk O
Mutat Res; 2011 Jun; 722(2):94-105. PubMed ID: 20472093
[TBL] [Abstract][Full Text] [Related]
14. [Pdcd4 tumor suppressor: properties, functions, and their application to oncology].
Vikhreva PN; Shepelev MV; Korobko EV; Korobko IV
Mol Gen Mikrobiol Virusol; 2010; (2):3-11. PubMed ID: 20545042
[TBL] [Abstract][Full Text] [Related]
15. Cancer genomics: the unknown unknowns.
Lotze MT; Yu Y
Curr Opin Investig Drugs; 2006 Jun; 7(6):497-500. PubMed ID: 16784019
[No Abstract] [Full Text] [Related]
16. CXCR4 and cancer.
Furusato B; Mohamed A; Uhlén M; Rhim JS
Pathol Int; 2010 Jul; 60(7):497-505. PubMed ID: 20594270
[TBL] [Abstract][Full Text] [Related]
17. Glioma stem cell signaling: therapeutic opportunities and challenges.
Dietrich J; Diamond EL; Kesari S
Expert Rev Anticancer Ther; 2010 May; 10(5):709-22. PubMed ID: 20470003
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis of cancer stem cells in human prostate cancer cells.
Lee EK; Cho H; Kim CW
Biochem Biophys Res Commun; 2011 Aug; 412(2):279-85. PubMed ID: 21820414
[TBL] [Abstract][Full Text] [Related]
19. The elaboration of a critical framework for understanding cancer: the cancer stem cell hypothesis.
Hemmings C
Pathology; 2010 Feb; 42(2):105-12. PubMed ID: 20085510
[TBL] [Abstract][Full Text] [Related]
20. Current status and issues in cancer stem cell study.
Yang YM; Chang JW
Cancer Invest; 2008 Aug; 26(7):741-55. PubMed ID: 18608212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
